Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients

BACKGROUND: Neoadjuvant Chemotherapy (NC) including trastuzumab induces a high rate of pathological Complete Responses (pCR) in patients with locally advanced HER2-overexpressing Breast Cancer (BC), but is penalized by a severe cardiotoxicity when combined with anthracyclines. A phase II study was d...

Descripción completa

Detalles Bibliográficos
Autores principales: Miolo, Gianmaria, Muraro, Elena, Martorelli, Debora, Lombardi, Davide, Scalone, Simona, Spazzapan, Simon, Massarut, Samuele, Perin, Tiziana, Viel, Elda, Comaro, Elisa, Talamini, Renato, Bidoli, Ettore, Turchet, Elisa, Crivellari, Diana, Dolcetti, Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302069/
https://www.ncbi.nlm.nih.gov/pubmed/25512030
http://dx.doi.org/10.1186/1471-2407-14-954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302069/
https://www.ncbi.nlm.nih.gov/pubmed/25512030
http://dx.doi.org/10.1186/1471-2407-14-954

Ejemplares similares